Showing results (551-560 of 3,934) with videos related to

Sort By:
Pageof 394
American Journal of Cancer Research|October 18, 2021
Assessment of TMB, PD-L1, and lymphocyte to monocyte ratio as predictive potential in a phase Ib study of sintilimab in patients with advanced solid tumorsHaiping Jiang, Ning Li, Huan Wang, et al.
American Journal of Cancer Research|October 18, 2021
A prognostic score based on long-term survivor unique transcriptomic signatures predicts patient survival in pancreatic ductal adenocarcinomaEriko Katsuta, Michelle Huyser, Li Yan, et al.
American Journal of Cancer Research|October 18, 2021
Downregulation of HOXC6 by miR-27a ameliorates gefitinib resistance in non-small cell lung cancerWenjuan He, Mingyang Qin, Yue Cai, et al.
American Journal of Cancer Research|October 18, 2021
Induction of cellular senescence in fibroblasts through β1-integrin activation by tenascin-C-derived peptide and its protumor effectMotomichi Fujita, Manabu Sasada, Mayu Eguchi, et al.
American Journal of Cancer Research|October 18, 2021
CSE1L silencing impairs tumor progression via MET/STAT3/PD-L1 signaling in lung cancerWeijun Liu, Zhiqing Zhou, Yu Li, et al.
American Journal of Cancer Research|October 18, 2021
PTEN inhibition leads to the development of resistance to novel isoquinoline derivative TNBG-5602 in human liver cancer cellsJing Wang, Yingbo Li, Chun-Mei Wan, et al.
American Journal of Cancer Research|October 18, 2021
Repurposing of posaconazole as a hedgehog/SMO signaling inhibitor for embryonal rhabdomyosarcoma therapyJingkai Sun, Wenfeng Lin, Chaoming Li, et al.
American Journal of Cancer Research|October 18, 2021
Genomic alterations in tumor tissue and ctDNA from Chinese pancreatic cancer patientsAnwen Xiong, Ning Ma, Guo Wei, et al.
American Journal of Cancer Research|October 18, 2021
Potent preclinical sensitivity to imipridone-based combination therapies in oncohistone H3K27M-mutant diffuse intrinsic pontine glioma is associated with induction of the integrated stress response, TRAIL death receptor DR5, reduced ClpX and apoptosisRobyn Borsuk, Lanlan Zhou, Wen-I Chang, et al.
American Journal of Cancer Research|October 18, 2021
Post-transplant lymphoproliferative disorders (PTLD)-from clinical to metabolic profiles-a single center experience and review of literatureGoni Katz-Greenberg, Sushil Ghimire, Tinging Zhan, et al.
Pageof 394